These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2121015)

  • 1. Comparison of coronary and myocardial morphologic findings in patients with and without thrombolytic therapy during fatal first acute myocardial infarction. The TIMI Investigators.
    Gertz SD; Kragel AH; Kalan JM; Braunwald E; Roberts WC
    Am J Cardiol; 1990 Oct; 66(12):904-9. PubMed ID: 2121015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac morphologic findings in patients with acute myocardial infarction treated with recombinant tissue plasminogen activator.
    Gertz SD; Kalan JM; Kragel AH; Roberts WC; Braunwald E
    Am J Cardiol; 1990 Apr; 65(15):953-61. PubMed ID: 2109524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Coronary thrombosis in patients who have died of acute myocardial infarct. A clinico-anatomical study of 167 successive cases].
    Perdigão C; Sendón JL; Monteiro J; Andrade A; Ribeiro C
    Rev Port Cardiol; 1993; 12(7-8):617-22, 599-600. PubMed ID: 8352981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sudden coronary death. Frequency of active coronary lesions, inactive coronary lesions, and myocardial infarction.
    Farb A; Tang AL; Burke AP; Sessums L; Liang Y; Virmani R
    Circulation; 1995 Oct; 92(7):1701-9. PubMed ID: 7671351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Status of the myocardium and infarct-related coronary artery in 19 necropsy patients with acute recanalization using pharmacologic (streptokinase, r-tissue plasminogen activator), mechanical (percutaneous transluminal coronary angioplasty) or combined types of reperfusion therapy.
    Waller BF; Rothbaum DA; Pinkerton CA; Cowley MJ; Linnemeier TJ; Orr C; Irons M; Helmuth RA; Wills ER; Aust C
    J Am Coll Cardiol; 1987 Apr; 9(4):785-801. PubMed ID: 2951422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes.
    Mizuno K; Satomura K; Miyamoto A; Arakawa K; Shibuya T; Arai T; Kurita A; Nakamura H; Ambrose JA
    N Engl J Med; 1992 Jan; 326(5):287-91. PubMed ID: 1728732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphologic comparison of frequency and types of acute lesions in the major epicardial coronary arteries in unstable angina pectoris, sudden coronary death and acute myocardial infarction.
    Kragel AH; Gertz SD; Roberts WC
    J Am Coll Cardiol; 1991 Sep; 18(3):801-8. PubMed ID: 1869744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and significance of right ventricular dysfunction during inferior wall left ventricular myocardial infarction treated with thrombolytic therapy (results from the thrombolysis in myocardial infarction [TIMI] II trial). The TIMI Research Group.
    Berger PB; Ruocco NA; Ryan TJ; Jacobs AK; Zaret BL; Wackers FJ; Frederick MM; Faxon DP
    Am J Cardiol; 1993 May; 71(13):1148-52. PubMed ID: 8097614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tissue plasminogen activator therapy on the frequency of acute right ventricular myocardial infarction associated with acute left ventricular infarction.
    Kalan JM; Gertz SD; Kragel AH; Berger PB; Roberts WC; Ryan TJ
    Int J Cardiol; 1993 Feb; 38(2):151-8. PubMed ID: 8454377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does tissue-type plasminogen activator have direct beneficial effects on the myocardium independent of its ability to lyse intracoronary thrombi?
    Kloner RA; Alker K; Campbell C; Figures G; Eisenhauer A; Hale S
    Circulation; 1989 May; 79(5):1125-36. PubMed ID: 2496937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Usefulness and safety of intravenous thrombolytic therapy for elderly patients with acute myocardial infarction: relationship with cardiac rupture].
    Sakai M; Imai T; Kuboki K; Maeda S; Ueda S; Kuwajima I; Ohkawa S; Matsushita S
    J Cardiol; 1999 Mar; 33(3):153-61. PubMed ID: 10225195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological characteristics of culprit atheromatic plaque are associated with coronary flow after thrombolytic therapy: new implications of optical coherence tomography from a multicenter study.
    Toutouzas K; Tsiamis E; Karanasos A; Drakopoulou M; Synetos A; Tsioufis C; Tousoulis D; Davlouros P; Alexopoulos D; Bouki K; Apostolou T; Stefanadis C
    JACC Cardiovasc Interv; 2010 May; 3(5):507-14. PubMed ID: 20488407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group.
    Grines CL; Browne KF; Marco J; Rothbaum D; Stone GW; O'Keefe J; Overlie P; Donohue B; Chelliah N; Timmis GC
    N Engl J Med; 1993 Mar; 328(10):673-9. PubMed ID: 8433725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with low-dose intracoronary recombinant tissue-type plasminogen activator for nonacute total occlusions before percutaneous transluminal coronary angioplasty.
    Ruocco NA; Currier JW; Jacobs AK; Ryan TJ; Faxon DP
    Am J Cardiol; 1991 Dec; 68(17):1609-13. PubMed ID: 1746461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of early accelerated dose tissue plasminogen activator on in-hospital patency of the infarcted vessel in patients with acute right ventricular infarction.
    Giannitsis E; Potratz J; Wiegand U; Stierle U; Djonlagic H; Sheikhzadeh A
    Heart; 1997 Jun; 77(6):512-6. PubMed ID: 9227293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis.
    Przyklenk K; Kloner RA
    Cardiovasc Res; 1993 Jun; 27(6):925-34. PubMed ID: 8221780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired ventricular septal defect during acute myocardial infarction: analysis of 38 unoperated necropsy patients and comparison with 50 unoperated necropsy patients without rupture.
    Mann JM; Roberts WC
    Am J Cardiol; 1988 Jul; 62(1):8-19. PubMed ID: 3381755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel model for evaluating thrombolytic therapy in dogs with ST-elevation myocardial infarction.
    Zhang H; Cui YC; Tian Y; Yuan WM; Yang JZ; Peng P; Li K; Liu XP; Zhang D; Wu AL; Zhou Z; Tang Y
    BMC Cardiovasc Disord; 2016 Jan; 16():21. PubMed ID: 26811249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolytic therapy for patients with prior percutaneous transluminal coronary angioplasty and subsequent acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
    Labinaz M; Sketch MH; Stebbins AL; DeFranco AC; Holmes DR; Kleiman NS; Betriu A; Rutsch WR; Vahanian A; Topol EJ; Califf RM
    Am J Cardiol; 1996 Dec; 78(12):1338-44. PubMed ID: 8970403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.